July 31, 2026
JBS: Updated Estimates, Outlook
Despite an improved outlook on Beef (all three regions), our Q2 and full-year estimates move lower. Our Q2 EBITDA estimate (GAAP basis) goes ~5% lower, but our full-year 2026 projection declines just 1% as a…
June 25, 2026
HJR Protein: Q2 Postmortem and Outlook
Q2 markets were characterized by continued margin deterioration. QTD broiler margins improved sequentially but currently lag the Q1 average. Both fresh pork and hog production margins contracted yr/yr and beef margins deteriorated further. Unsurprisingly, the…
May 21, 2026
JBS: Updated Estimates, Outlook
JBS reported Q1 results modestly ahead of our estimates (EBITDA ~$30MM) had we adjusted our estimate for Pilgrim’s previously reported Q1 shortfall. Relative to us, outperformance was driven primarily by NA Beef/Pork and JBS Brasil,…
May 20, 2026
China’s Ag Evolution: Global S&D Implications
China’s latest (15th) Five-Year Plan (2026-2030) approved this past March echoed the 14th FYP’s emphasis upon foodstuff security as a priority. The latest iteration calls out diversification and modernization of agricultural systems as key to…
April 2, 2026
JBS: Updated Estimates, Outlook
JBS reported Q4 results nicely ahead of our expectations driven by outperformance in Australia and JBS Brasil. Within the latter, we believe lower-than-expected corporate expense was the primary driver versus our estimates, while Australia benefited…
March 20, 2026
Iran War: Impact to Coverage
Our coverage is greatly impacted by most global conflicts, given its intersection with global grain and energy markets. The Iran conflict’s impact on energy prices was immediate, but reverberations are expanding each day as critical…
March 12, 2026
JBS: Updated Estimates, Outlook
We have raised our Q4 estimate (recall our projections are U.S. GAAP) as PPC’s Q4 results were better-than-expected; we also believe Seara and JBS Brasil performed somewhat better than previously anticipated. We did not change…
January 26, 2026
HJR Protein: Updated Outlook/Est Revisions
S&D dynamics should remain favorable for much of our coverage in 2026, but we continue to believe full-year conditions will be looser than last year in both the U.S. and ROW. Given disease and weather,…
November 24, 2025
JBS: Updated Outlook, Estimates
JBS reported strong Q3 results with the upside, relative to us (nearly $95M upside on the EBITDA line, or ~6%), driven by its U.S. red meat operations. We believe favorable movements in its derivative positions…
November 10, 2025
JBS: Initiating Coverage
We are initiating coverage of JBS, the largest animal protein producer in the world with operations that span much of the globe (55%-65% EBITDA derived from U.S. operations) and include most species, including cattle, chicken,…
